Literature DB >> 24880126

Heat shock protein 90β stabilizes focal adhesion kinase and enhances cell migration and invasion in breast cancer cells.

Xiangyang Xiong1, Yao Wang2, Chengmei Liu3, Quqin Lu4, Tao Liu2, Guoan Chen5, Hai Rao6, Shiwen Luo7.   

Abstract

Focal adhesion kinase (FAK) acts as a regulator of cellular signaling and may promote cell spreading, motility, invasion and survival in malignancy. Elevated expression and activity of FAK frequently correlate with tumor cell metastasis and poor prognosis in breast cancer. However, the mechanisms by which the turnover of FAK is regulated remain elusive. Here we report that heat shock protein 90β (HSP90β) interacts with FAK and the middle domain (amino acids 233-620) of HSP90β is mainly responsible for this interaction. Furthermore, we found that HSP90β regulates FAK stability since HSP90β inhibitor 17-AAG triggers FAK ubiquitylation and subsequent proteasome-dependent degradation. Moreover, disrupted FAK-HSP90β interaction induced by 17-AAG contributes to attenuation of tumor cell growth, migration, and invasion. Together, our results reveal how HSP90β regulates FAK stability and identifies a potential therapeutic strategy to breast cancer.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Breast cancer; FAK; HSP90β; Metastasis; Ubiquitin

Mesh:

Substances:

Year:  2014        PMID: 24880126      PMCID: PMC4120946          DOI: 10.1016/j.yexcr.2014.05.018

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  56 in total

1.  Structural basis for recruitment of the ATPase activator Aha1 to the Hsp90 chaperone machinery.

Authors:  Philippe Meyer; Chrisostomos Prodromou; Chunyan Liao; Bin Hu; S Mark Roe; Cara K Vaughan; Ignacija Vlasic; Barry Panaretou; Peter W Piper; Laurence H Pearl
Journal:  EMBO J       Date:  2004-03-24       Impact factor: 11.598

2.  Phase I pharmacokinetic and pharmacodynamic study of 17-allylamino, 17-demethoxygeldanamycin in patients with advanced malignancies.

Authors:  Udai Banerji; Anne O'Donnell; Michelle Scurr; Simon Pacey; Sarah Stapleton; Yasmin Asad; Laura Simmons; Alison Maloney; Florence Raynaud; Maeli Campbell; Michael Walton; Sunil Lakhani; Stanley Kaye; Paul Workman; Ian Judson
Journal:  J Clin Oncol       Date:  2005-06-20       Impact factor: 44.544

3.  Mapping the HSP90 binding region of the glucocorticoid receptor.

Authors:  K J Howard; S J Holley; K R Yamamoto; C W Distelhorst
Journal:  J Biol Chem       Date:  1990-07-15       Impact factor: 5.157

Review 4.  Focal adhesion kinase signaling activities and their implications in the control of cell survival and motility.

Authors:  Steven K Hanks; Larisa Ryzhova; Nah-Young Shin; Jan Brábek
Journal:  Front Biosci       Date:  2003-05-01

5.  Inhibition of heat shock protein 90 function by 17-allylamino-17-demethoxy-geldanamycin in Hodgkin's lymphoma cells down-regulates Akt kinase, dephosphorylates extracellular signal-regulated kinase, and induces cell cycle arrest and cell death.

Authors:  Georgios V Georgakis; Yang Li; Georgios Z Rassidakis; Hector Martinez-Valdez; L Jeffrey Medeiros; Anas Younes
Journal:  Clin Cancer Res       Date:  2006-01-15       Impact factor: 12.531

6.  Lipid rafts serve as a signaling platform for nicotinic acetylcholine receptor clustering.

Authors:  Dan Zhu; Wen C Xiong; Lin Mei
Journal:  J Neurosci       Date:  2006-05-03       Impact factor: 6.167

7.  Inhibition of mouse bladder tumor proliferation by murine interferon-gamma and its synergism with interferon-beta.

Authors:  T L Ratliff; D Kadmon; A Shapiro; A J Jacobs; W D Heston
Journal:  Cancer Res       Date:  1984-10       Impact factor: 12.701

8.  The benzoquinone ansamycin geldanamycin stimulates proteolytic degradation of focal adhesion kinase.

Authors:  H J Ochel; T W Schulte; P Nguyen; J Trepel; L Neckers
Journal:  Mol Genet Metab       Date:  1999-01       Impact factor: 4.797

9.  Phase I trial of 17-allylamino-17-demethoxygeldanamycin in patients with advanced cancer.

Authors:  David B Solit; S Percy Ivy; Catherine Kopil; Rachel Sikorski; Michael J Morris; Susan F Slovin; W Kevin Kelly; Anthony DeLaCruz; Tracy Curley; Glenn Heller; Steven Larson; Lawrence Schwartz; Merrill J Egorin; Neal Rosen; Howard I Scher
Journal:  Clin Cancer Res       Date:  2007-03-15       Impact factor: 12.531

Review 10.  Paxillin comes of age.

Authors:  Nicholas O Deakin; Christopher E Turner
Journal:  J Cell Sci       Date:  2008-08-01       Impact factor: 5.285

View more
  9 in total

1.  Fever Promotes T Lymphocyte Trafficking via a Thermal Sensory Pathway Involving Heat Shock Protein 90 and α4 Integrins.

Authors:  ChangDong Lin; YouHua Zhang; Kun Zhang; YaJuan Zheng; Ling Lu; HaiShuang Chang; Hui Yang; YanRong Yang; YaoYing Wan; ShiHui Wang; MengYa Yuan; ZhanJun Yan; RongGuang Zhang; YongNing He; GaoXiang Ge; Dianqing Wu; JianFeng Chen
Journal:  Immunity       Date:  2019-01-15       Impact factor: 31.745

2.  Overcoming Limitations of Cisplatin Therapy by Additional Treatment With the HSP90 Inhibitor Onalespib.

Authors:  Anja Charlotte Lundgren Mortensen; Tabassom Mohajershojai; Mehran Hariri; Marika Pettersson; Diana Spiegelberg
Journal:  Front Oncol       Date:  2020-09-30       Impact factor: 6.244

3.  Leukocyte integrin α4β7 associates with heat shock protein 70.

Authors:  Yih-Chih Chan; David R Greenwood; Yi Yang; Euphemia Leung; Geoffrey W Krissansen
Journal:  Mol Cell Biochem       Date:  2015-08-11       Impact factor: 3.396

4.  Absence of AIF1L contributes to cell migration and a poor prognosis of breast cancer.

Authors:  Peipei Liu; Wenhui Li; Yuanyuan Hu; Youhong Jiang
Journal:  Onco Targets Ther       Date:  2018-09-05       Impact factor: 4.147

Review 5.  Emerging Functions of Human IFIT Proteins in Cancer.

Authors:  Vijaya Kumar Pidugu; Hima Bindu Pidugu; Meei-Maan Wu; Chung-Ji Liu; Te-Chang Lee
Journal:  Front Mol Biosci       Date:  2019-12-19

6.  DNAJC12 as a Mediator Between ESR1 and ERBB4 in Breast Carcinoma Cells.

Authors:  Mianjie Lin; Ya-Nan Wang; Yixin Ye; Zhelei Xiong; Fengbiao Guo; Haibin Chen
Journal:  Front Oncol       Date:  2021-02-24       Impact factor: 6.244

Review 7.  Focal Adhesion Kinase Fine Tunes Multifaced Signals toward Breast Cancer Progression.

Authors:  Damiano Cosimo Rigiracciolo; Francesca Cirillo; Marianna Talia; Lucia Muglia; Jorge Silvio Gutkind; Marcello Maggiolini; Rosamaria Lappano
Journal:  Cancers (Basel)       Date:  2021-02-05       Impact factor: 6.639

Review 8.  Endogenous Control Mechanisms of FAK and PYK2 and Their Relevance to Cancer Development.

Authors:  Rayan Naser; Abdullah Aldehaiman; Escarlet Díaz-Galicia; Stefan T Arold
Journal:  Cancers (Basel)       Date:  2018-06-11       Impact factor: 6.639

9.  EEF1A2 interacts with HSP90AB1 to promote lung adenocarcinoma metastasis via enhancing TGF-β/SMAD signalling.

Authors:  Liqing Jia; Xiaolu Ge; Chao Du; Linna Chen; Yanhong Zhou; Wei Xiong; Juanjuan Xiang; Guiyuan Li; Gaoming Xiao; Li Fang; Zheng Li
Journal:  Br J Cancer       Date:  2021-01-21       Impact factor: 9.075

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.